No effect of danazol treatment in patients with advanced idiopathic pulmonary fibrosis.
Thijs W HoffmanColine H M van MoorselJoanne J van der VisDouwe H BiesmaJan C GruttersPublished in: ERJ open research (2023)
Danazol as a treatment of last resort in patients with IPF did not lead to slowing of lung function decline and was associated with significant side-effects. It remains to be determined if earlier treatment or treatment of specific patient subgroups is beneficial.